Q32 Bio (QTTB) Total Liabilities (2017 - 2026)

Q32 Bio's Total Liabilities history runs 10 years deep, the most recent figure standing at $17.4 million for Q1 2026.

• On a quarterly basis, Total Liabilities fell 79.1% year-over-year to $17.4 million in Q1 2026; TTM through Mar 2026 was $17.4 million, a 79.1% decrease from a year earlier, with the FY2025 full-year figure at $19.8 million, down 77.2% from the prior year.
• Total Liabilities declined to $17.4 million in Q1 2026 per QTTB's latest filing, from $19.8 million in the prior quarter.
• Across five years, Total Liabilities topped out at $118.5 million in Q4 2023 and bottomed at $17.4 million in Q1 2026.
• The 5-year median for Total Liabilities is $53.6 million (2022), against an average of $64.8 million.
• Across the five-year window, Total Liabilities surged 134.76% in 2023 and tumbled 79.1% in 2026, its largest moves.
• Year by year, Total Liabilities stood at $50.5 million in 2022, then jumped by 134.76% to $118.5 million in 2023, then slipped by 26.89% to $86.7 million in 2024, then slumped by 77.2% to $19.8 million in 2025, then retreated by 12.14% to $17.4 million in 2026.
• Per Business Quant, the three latest QTTB Total Liabilities figures stand at $17.4 million (Q1 2026), $19.8 million (Q4 2025), and $76.2 million (Q3 2025).